I’ve been in the research chemical scene for a long time now and through the years I’ve ingested many, many substances to extrapolate their effects. This really is all research to find out the Research chemicals between different compounds. Basically what compounds hit which receptors and what will happen following that. On my small journey I’ve been as far as you can go with regards to “highness”!
Even so the research chemical scene today is dwindling. It’s still producing many novel compounds to bypass laws only in the most famous areas, which are most often the empathogens, stimulants and cannabinoids. We have 5-EAPB, a-PVP, MPA and numerous cannabinoids which seem to pop up faster than you may also fully understand the last. My favourites from the cannabinoids have to be the cannabinoid re-uptake inhibitors like LY-2183240. These compounds don’t actually agonise your cannabinoid receptors as Cannabis along with other cannabinoids do nonetheless they increase your own endogenous cannabinoids, so essentially you’re getting high off your personal juices! When these are typically combined with agonists such as THC or other synthetic cannabinoids, they improve the high to this sort of extent which a gram of weed could last weekly with say 20mg of your CRI’s! Now that is innovation.
I’m not here to speak to you about 4F-PHP though. Exactly what is really on my small agenda is lacking innovation within the psychedelic realm. PIHKAL and TIHKAL have offered us hundreds of compounds that could be made yet only the standard are marketed. Now to me this can be a problem. I adore novel psychedelics. In fact I was able to name just a few i made up here and from now on (i.e. 2C-MAL, 4-Bromo-Mescaline, 4-PropO-PiPT etc.).
The simple fact in the matter is no-one is producing novel psychedelics anymore. There were a number of within the last couple of years that had been great such as 3C-E and bk-2C-B but in addition to those (rather meagre) psychedelics, we have seen no big bangs, which happens to be things i love. The compounds that could be a large hit are: 5-TOET, ALEPH & ALEPH-2, 2C-EF, 2C-TFM, CPM, 2C-T-21, DMMDA, psi-DOx (these have lowered duration for many who aren’t fans of long psychedelics), MEM, MMDA-2, MMDA-3a (and it’s methyl analogue), MMDA itself (effective at producing ‘brain movies’) and a whole host of other analogues as an illustration 2C-C-FLY.
I have got to present praise to many that are producing such compounds though as DON, DOET, LSZ, AL-LAD and 2C-B-FLY make it onto the scene recently.
However my main message in this particular is the fact that as darknets are expanding, the requirement for analogues and research chemicals is now redundant. People would rather have a gram of MDMA when compared to a gram of ethyl-hexedrone. They’d rather get some 2C-B than some 2C-T-16 or 2C-YN. The research chemical scene used to be thriving and everybody wished to make their 87dexlpky around the world. Just have a look at how well MXE has done, and this is simply not even near to what could be. With some imagination and drive, even better compounds could possibly be created. They also need to be distributed in the retail end since there are many wholesalers that do produce fantastic products but customers are so dead set on which they are aware and desire there is absolutely no room for expansion.
Whenever we are to evolve chemically we should begin to abandon the fundamental drugs we realize and love. It’s a risky venture, naturally, but people who use drugs participate in risky behaviour all the time, why not expand those boundaries to allow in several of the fantastic compounds which are out there waiting to be synthesized? This can be evolution at it’s simplest definition with the introduction of Black Marketplaces it appears to be our company is with a lull, our company is not striving on the future but perhaps, someday, we’ll get out of bed and realise the compounds many have neglected are the type that they want the most.